---
figid: PMC8145311__brainsci-11-00583-g007
figtitle: 'Distinguishing Alzheimer’s Disease Patients and Biochemical Phenotype Analysis
  Using a Novel Serum Profiling Platform: Potential Involvement of the VWF/ADAMTS13
  Axis'
organisms:
- NA
pmcid: PMC8145311
filename: brainsci-11-00583-g007.jpg
figlink: /pmc/articles/PMC8145311/figure/brainsci-11-00583-f007/
number: F7
caption: IPA of m/z “range” MS/MS serum data from mild AD patients vs. control subject
  comparison using top 119 peptides/proteins from  and . IPA m/z range MS/MS serum
  data analysis for mild AD patients vs. controls using top 119 peptide/proteins from  and
  . Ingenuity Pathway Analysis (IPA), Qiagen, Inc.) of the 119 peptides/proteins exhibited
  in  and  having a 2x difference in positive sera number between mild AD patients
  and controls, and a 1.5x difference in MS/MS “hit” [single-peptide identification]
  ratio between the two groups. The protein function symbol legend is at the bottom
  of the figure.
papertitle: 'Distinguishing Alzheimer’s Disease Patients and Biochemical Phenotype
  Analysis Using a Novel Serum Profiling Platform: Potential Involvement of the VWF/ADAMTS13
  Axis.'
reftext: Jay S. Hanas, et al. Brain Sci. 2021 May;11(5):583.
year: '2021'
doi: 10.3390/brainsci11050583
journal_title: Brain Sciences
journal_nlm_ta: Brain Sci
publisher_name: MDPI
keywords: Alzheimer’s disease (AD) | biochemical phenotype analysis | serum profiling
  | mass spectrometry | VWF/ADAMTS13 axis | traumatic brain injury (TBI) | SSPO AD
  biomarker
automl_pathway: 0.895999
figid_alias: PMC8145311__F7
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8145311__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8145311__brainsci-11-00583-g007.html
  '@type': Dataset
  description: IPA of m/z “range” MS/MS serum data from mild AD patients vs. control
    subject comparison using top 119 peptides/proteins from  and . IPA m/z range MS/MS
    serum data analysis for mild AD patients vs. controls using top 119 peptide/proteins
    from  and . Ingenuity Pathway Analysis (IPA), Qiagen, Inc.) of the 119 peptides/proteins
    exhibited in  and  having a 2x difference in positive sera number between mild
    AD patients and controls, and a 1.5x difference in MS/MS “hit” [single-peptide
    identification] ratio between the two groups. The protein function symbol legend
    is at the bottom of the figure.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGLL1
  - ASCC1
  - ZNF592
  - YEATS2
  - GATAD2A
  - PARP4
  - ND1
  - IGKC
  - BOC
  - CYLD
  - SNTB2
  - ATP1A1
  - ATP1A3
  - ATP1A4
  - BSG
  - ARHGEF2
  - KHSRP
  - SRRM2
  - CR1
  - CRIPTO
  - RIF1
  - INSL6
  - LRIF1
  - SSPOP
  - ND6
  - CAPN3
  - TSHZ2
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - BCAR1
  - CACNA1G-AS1
  - PCDHA4
  - LRP4
  - CORIN
  - OMA1
  - POTEB3
  - TNFAIP3
  - HSPG2
  - VWF
  - BLTP1
  - LTBP1
  - GRN
  - ITGB2
  - POTEB
  - POTEB2
  - ITGAX
  - LRP1
  - C1D
  - EGR1
  - CTCF
  - ADAMTS13
  - ZBTB8OS
  - AGAP2
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - GNAS
  - GNAL
  - GNAQ
  - GNA11
  - GNA14
  - GNA15
  - GNA12
  - GNA13
  - UPF2
  - POU4F3
  - CSMD1
  - EYA1
  - SH3PXD2A
  - NAAA
  - LTBP2
  - LTBP3
---
